Amanote Research
Register
Sign In
Intravenous Immune Globulins in Patients With Guillain-Barre Syndrome and Contraindications to Plasma Exchange: 3 Days Versus 6 Days
Journal of Neurology, Neurosurgery and Psychiatry
- United Kingdom
doi 10.1136/jnnp.71.2.235
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Mental Health
Neurology
Surgery
Date
August 1, 2001
Authors
J-C Raphael
Publisher
BMJ
Related search
Intravenous Immunoglobulins Versus Plasma Exchange in the Treatment of Guillain-Barré Syndrome
Critical Care
Critical Care
Intensive Care Medicine
Lymphocyte Sensitization to Nervous Tissues and Muscle in Patients With the Guillain-Barre Syndrome
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Guillain-Barre Syndrome With Antibodies to GD1a/GD1b Complex
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Guillain-Barre Syndrome: Case Report
Guillain-Barre Syndrome Associated With Idiopathic Thrombocytopenic Purpura.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Clinical Characteristics of Intravenous Injection of Monosialotetrahexosyl Ganglioside Sodium-Related Guillain-Barre Syndrome
Frontiers in Neurology
Neurology
Ventilatory Failure in the Guillain-Barre Syndrome.
Thorax
Pulmonary
Respiratory Medicine
Short Report: Immune Response to Gangliosides in a Case of Guillain-Barre Syndrome After Varicella
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Antibiotic Treatment for 6 Days Versus 12 Days in Patients With Severe Cellulitis: A Multicentre Randomised, Double-Blind, Placebo-Controlled, Non-Inferiority Trial
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
